Autopsy report · NCT02696226

Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.

“Poor enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 5 months before it stopped.
• 3 participants enrolled.
• Results were posted on the registry 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

The Cleveland Clinic

Sponsor type

University, hospital or other

Conditions

Aortic Valve Disorder

Interventions

SAVR Warfarin; SAVR Aspirin; TAVR Warfarin and clopidogrel; TAVR Aspirin and clopidogrel

Participants

3

Sites

1

Countries

United States

Trials that died the same way

• Use of Prokinetics in Early Enteral Feeding in Preterm Infants
  “very poor enrollment” (96% match in meaning)
• Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBC
  “Inadequate enrollment” (91% match in meaning)
• Tocilizumab for the Treatment of Behcet's Syndrome
  “low enrollment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.